CombiMatrix, Illumina Report Q3 Revenue Growth, But Investors Remain Unimpressed | GenomeWeb

CombiMatrix reported gains in revenue and a decrease in its net loss for the third quarter, as the firm continued its evolution from a microarray products firm to a diversified biotech and nanotechnology concern.

The life sciences unit of Acacia Research reported total revenue of $753,000 for the quarter, a significant gain on revenue of $181,000 in the third quarter of 2003. Its revenues were flat from the second quarter and fell far short of analysts’ expectations of $1.1 million.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.